Bìol. Tvarin, 2015, volume 17, issue 2, pp. 50–56


O. P. Dolaychuk, R. S. Fedoruk, I. I. Kovalchuk, S. Y. Kropyvka

іThis email address is being protected from spambots. You need JavaScript enabled to view it.

Institute of Animal Biology NAAS,
Laboratory of ecological physiology and quality of productions,
38 Vasyl Stus str., Lviv 79034, Ukraine

Organic germanium compounds are characterized by a wide spectrum of effect on the organisms of people and animals and are used as a food supplement to enhance the immunological organism reactivity. However, using of the toxic inorganic forms as precursors for obtaining organic germanium compounds by chemical synthesis indicates the urgency of searching for the alternative ways to get them. This article presents the results of the study of the influence of different amounts of germanium citrate, which was obtained by electric impulse nanotechnology method, onto the physiological processes in rat organismto determine the optimal dose. The germanium citrate solutions with the concentrations of 10, 200, and 300 µg of Ge/L were used in the study. It was determined that feeding with germanium with the concentration of 10 µg of Ge/L did not show significant changes of the studied parameters. While an elevated concentration of hemoglobin, circulating immune complexes, and average weight molecules were observed in the blood of the rats, which were fed with germanium citrate with the concentrations of 200 and 300 µg of Ge/L. Such changes may indicate the immunomodulatory properties of the germanium citrate. Probable decrease in the concentration of the lipid hydroperoxides and TBA-active products in the blood of the animals, which were fed with the germanium citrate with the concentrations of 200 and 300 µg of Ge/L of water, was also found out. More effective physiological influence of the germanium onto the peroxidation processes was noticed in case of feeding its citrate with the concentrations of 200 and 300 µg of Ge/L. So feeding with the germanium citrate, produced with the help of the nanotechnology method, improves the immunological indicators and reduces the intensity of the lipid peroxidation of the infant rats.


  1. Gielen M, Tiekink E. R. T. Metallotherapeutic Drugs and Metal-based Diagnostic Agents: The Use of Metals in Medicine. Wiley, 2005, 638 p. https://doi.org/10.1002/0470864052
  2. Shangguan G. Q., Zhang S. G., Ni J. Z. Synthesis, structures and antitumor activities of beta-phenolester propyl germanium sesquioxides. Chinese Chem. Lett., 1995, 6, pp. 945–946.
  3. Shangguan G., Xing F., Qu X., Mao J., Zhao D., Zhao X., Ren J. DNA binding specificity and cytotoxicity of novel antitumor agent Ge132 derivatives. Bioorg Med Chem Lett., 2005, 15, pp. 2962–2965. https://doi.org/10.1016/j.bmcl.2005.04.053
  4. Shangguan G. Q., Huang L. L., Qu M. G. The synthesis and cytotoxic activity of novel organogermanium sesquioxides with anthraquinone or naphthalene moiety. Chinese Chem. Lett., 2007, 18, pp. 1347–1350. https://doi.org/10.1016/j.cclet.2007.09.029
  5. Zhang C. L., Li T. H., Niu S. H., Wang R. F., Fu Z. L., Guo F. Q., Yang M. Synthesis and evaluation of novel organogermanium sesquioxides as antitumor agents. Bioinorg. Chem. Appl., 2009, article ID 908625, pp. 1–8.
  6. Aso H., Suzuki F., Yamaguchi T., Hayashi Y., Ebina T., Ishida N. Induction of interferon and activation of NK cells and macrophages in mice by oral administration of Ge-132, an organic germanium compound. Microbiol. Immunol., 1985, 29, pp. 65–74. https://doi.org/10.1111/j.1348-0421.1985.tb00803.x
  7. Mrema J. E., Slavik M., Davis J. Spirogermanium: a new drug with antimalarial activity against chloroquine-resistant Plasmodium falciparum. Int. J. Clin. Pharmacol. Ther. Toxicol., 1983, 21, pp. 167–171.
  8. Slavik M., Blanc O., Davis J. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity. Invest New Drugs, 1983, 1, pp. 225–234. https://doi.org/10.1007/BF00208894
  9. Ishiwata Y., Yokochi S., Suzuki E., Michishita H., Tashita A., Asano K., Mitani T., Kurono M. Effects of proxigermanium on interferon production and 2’,5’-oligoadenylate synthetase activity in the lung of influenza virus-infected mice and in virus-infected human peripheral blood mononuclear cell cultures. Arznei-Forschung, 1990, 40, pp. 896–899.
  10. Suzuki F Antitumor mechanisms of carboxyethyl-germanium sesquioxide (Ge-132) in mice bearing Ehrlich ascites tumors. Gan To Kagaku Ryoho, 1987, 14, pp. 127–134.
  11. Nagata N., Yoneyama T., Yanagida K., Ushio K., Yanagihara S., Matsubara O., Eishi Y. Accumulation of germanium in the tissues of a long-term user of germanium preparation died of acute renal failure. J. Toxicol. Sci., 1985, 10, pp. 333–341. https://doi.org/10.2131/jts.10.333
  12. Gerber G. B., Leonard A. Mutagenicity, carcinogenicity and teratogenicity of germanium compounds. Mutat. Res.-Rev. Mutat., 1997, 387, pp. 141–146. https://doi.org/10.1016/S1383-5742(97)00034-3
  13. Lin C. H., Chen T. J., Hsieh Y. L., Jiang S. J, Chen S. S. Kinetics of germanium dioxide in rats. Toxicology, 1999, 132, pp. 147–153. https://doi.org/10.1016/S0300-483X(98)00147-4
  14. Tao S. H., Bolger P. M. Hazard assessment of germanium supplements. Regul. Toxicol. Pharmacol., 1997, 25, pp. 211–219. https://doi.org/10.1006/rtph.1997.1098
  15. Fedoruk R. S., Khomyn N. M., Khomyn M. M. Physiological and biochemical impact nanoparticles of chromium and selenium citrate in the body young rats. The Animal Biology, 2013, vol. 15, no. 4, pp. 141–149. (in Ukrainian)
  16. Khomyn M. M., Fedoruk R. S. Antioxidant profile of organism and biological value of milk of cows in the first months of lactation under feeding by chromium and selenium citrate. The Animal Biology, 2013, vol. 15, no. 2, pp. 140–149. (in Ukrainian)
  17. Lesyk Ya. V., Fedoryk R. S., Kropyvka S. J., Dolaychyk O. P. Physiological and biochemical parameters of blood and semen quality of rabbits, watering sulfur and chromium compounds. The Animal Biology, 2014, vol. 16, no. 1, pp. 104–111. (in Ukrainian)
  18. Kosinov M.. V., Kaplunenko V. H. Method of metal carboxylates “Nanotechnology of metal carboxylates”. Patent U. no. 38391, 2009. (in Ukrainian)
  19. European convention for the protection of vertebrate animals used for experim. and other scientific purposes. Coun. of Europe, Strasbourg, 1986, p. 53.
  20. Vlizlo V. V. Laboratory research methods in biology, animal husbandry and veterinary medicine. Lviv, Spolom, 2012, pp. 355–368. (in Ukrainian)
  21. Kotsyumbas I. Ya. Preclinical studies of veterinary medicines. Lviv, Triada plus, 2006, 360 p. (in Ukrainian)
  22. Yang M. K., Kim Y. G. Protective role of germanium-132 against paraquat-induced oxidative stress in the livers of senescence-accelerated mice. J. Toxicol. Environ. Health A., 1999, 12, 58 (5), pp. 289–297.
  23. Xie W., Chen X., Yang K. Effects of selenium and germanium on lipid peroxidation in rats fed with low-selenium grain. Zhonghua Yu Fang Yi Xue Za Zhi, 1996, 30 (2), pp. 88–90.
  24. Furst A. Biological Testing of Germanium. Toxicology and industrial health, 1987, 3 (1), pp. 167–204. https://doi.org/10.1177/074823378700300107

Download full text in PDF format




WorldCat Logo